Arch Therapeutics OTC Stock Forecast - 8 Period Moving Average
| ARTH Stock | USD 0.21 0.01 5.00% |
The 8 Period Moving Average forecasted value of Arch Therapeutics on the next trading day is expected to be 0.21 with a mean absolute deviation of 0.07 and the sum of the absolute errors of 3.64. Arch OTC Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Arch Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Arch |
Arch Therapeutics 8 Period Moving Average Price Forecast For the 3rd of December
Given 90 days horizon, the 8 Period Moving Average forecasted value of Arch Therapeutics on the next trading day is expected to be 0.21 with a mean absolute deviation of 0.07, mean absolute percentage error of 0.01, and the sum of the absolute errors of 3.64.Please note that although there have been many attempts to predict Arch OTC Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Arch Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Arch Therapeutics OTC Stock Forecast Pattern
| Backtest Arch Therapeutics | Arch Therapeutics Price Prediction | Buy or Sell Advice |
Arch Therapeutics Forecasted Value
In the context of forecasting Arch Therapeutics' OTC Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Arch Therapeutics' downside and upside margins for the forecasting period are 0 and 18.93, respectively. We have considered Arch Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 8 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Arch Therapeutics otc stock data series using in forecasting. Note that when a statistical model is used to represent Arch Therapeutics otc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 98.7014 |
| Bias | Arithmetic mean of the errors | 0.0413 |
| MAD | Mean absolute deviation | 0.0688 |
| MAPE | Mean absolute percentage error | 0.2177 |
| SAE | Sum of the absolute errors | 3.6438 |
Predictive Modules for Arch Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Arch Therapeutics. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Arch Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Arch Therapeutics
For every potential investor in Arch, whether a beginner or expert, Arch Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Arch OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Arch. Basic forecasting techniques help filter out the noise by identifying Arch Therapeutics' price trends.Arch Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Arch Therapeutics otc stock to make a market-neutral strategy. Peer analysis of Arch Therapeutics could also be used in its relative valuation, which is a method of valuing Arch Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Arch Therapeutics Technical and Predictive Analytics
The otc stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Arch Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Arch Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Arch Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Arch Therapeutics otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arch Therapeutics shares will generate the highest return on investment. By undertsting and applying Arch Therapeutics otc stock market strength indicators, traders can identify Arch Therapeutics entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.05 | |||
| Day Median Price | 0.21 | |||
| Day Typical Price | 0.21 | |||
| Price Action Indicator | 0.005 | |||
| Period Momentum Indicator | 0.01 | |||
| Relative Strength Index | 43.83 |
Arch Therapeutics Risk Indicators
The analysis of Arch Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Arch Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting arch otc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 12.64 | |||
| Semi Deviation | 15.32 | |||
| Standard Deviation | 18.72 | |||
| Variance | 350.47 | |||
| Downside Variance | 429.15 | |||
| Semi Variance | 234.76 | |||
| Expected Short fall | (19.51) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
Other Information on Investing in Arch OTC Stock
Arch Therapeutics financial ratios help investors to determine whether Arch OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arch with respect to the benefits of owning Arch Therapeutics security.